Aljafary Meneerah Abdulrahman, Al-Suhaimi Ebtesam Abdullah
Biology Department, College of Science, Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Pharmaceutics. 2022 Jul 7;14(7):1430. doi: 10.3390/pharmaceutics14071430.
The adipose tissue, regardless of its role in generating and storing energy, acts as a key player as an endocrine tissue, producing a wide scale of cytokines/hormones called adipokines. Adipokines such as leptin, resistin, visfatin and osteopontin own pro-inflammatory effects on the cardiovascular system in some cases. In contrast, some adipokines have cardioprotective and anti-inflammatory impacts including adiponectin, omentin, and apelin. One of the key adipokines is adiponectin, the abundant peptide regulating hormone that is released mainly by adipocytes and cardiomyocytes as well as by endothelial and skeletal cells. It acts through two main receptors: AdipoR1 and AdipoR2, forming the "Adiponectin system" which effectively exerts its cellular mechanisms and responses in target cells. It regulates various metabolic processes, while adiponectin is the adipocyte hormone known for its cardioprotective impact in clinical and experimental research. It is also a well-effector metabolic adipokine, since weight loss or diet restriction show a link with rises in adiponectin concentrations, which is accompanied with increasing insulin sensitivity, glucose, and lipids-regulation via adiponectin's antioxidant, anti-inflammatory, anti-fibrotic actions. The high adiponectin level made it an attractive player in developing therapeutical treatments for metabolic syndromes and cardiovascular disease. The elevated plasma levels of adiponectin are mostly attributed to its benefits on cardio-metabolism. In some cases, adiponectin has been paradoxically accompanied with elevated risk of cardiovascular disease, so higher adiponectin concentration is a marker of poor prediction. Thus, the adiponectin system is attractive to researchers as a biomarker of heart disease advancement and a predictor of prognosis during the term of some cardiovascular diseases and its mechanical functions in Hypertension and diabetic patients. This review highlights the physiological roles of adiponectin as an anti-inflammatory and cardioprotective hormone as well as how it plays as a biomarker and potential therapeutic tool in the cardiovascular system in adult, children, and adolescents. The adiponectin system may be seen as a rescue hormone aiding in remodeling of the cardiovascular system on both cellular and molecular levels. The paradox role of adiponectin relevant to cardiovascular mortality should be taken into consideration.
脂肪组织,无论其在能量产生和储存中的作用如何,作为一种内分泌组织都起着关键作用,能产生一系列被称为脂肪因子的细胞因子/激素。一些脂肪因子,如瘦素、抵抗素、内脂素和骨桥蛋白,在某些情况下对心血管系统具有促炎作用。相比之下,一些脂肪因子具有心脏保护和抗炎作用,包括脂联素、网膜素和Apelin。关键的脂肪因子之一是脂联素,这是一种丰富的肽调节激素,主要由脂肪细胞、心肌细胞以及内皮细胞和骨骼肌细胞释放。它通过两种主要受体发挥作用:AdipoR1和AdipoR2,形成“脂联素系统”,该系统在靶细胞中有效地发挥其细胞机制和反应。它调节各种代谢过程,而脂联素是在临床和实验研究中因其心脏保护作用而闻名的脂肪细胞激素。它也是一种有效的代谢脂肪因子,因为体重减轻或饮食限制与脂联素浓度升高有关,同时通过脂联素的抗氧化、抗炎、抗纤维化作用提高胰岛素敏感性、调节葡萄糖和脂质。高浓度的脂联素使其成为开发代谢综合征和心血管疾病治疗方法的有吸引力的因素。脂联素血浆水平升高主要归因于其对心脏代谢的益处。在某些情况下,脂联素却与心血管疾病风险升高存在矛盾关系,因此较高的脂联素浓度是预测不良的指标。因此,脂联素系统作为心脏病进展的生物标志物以及某些心血管疾病期间预后的预测指标及其在高血压和糖尿病患者中的机械功能,对研究人员具有吸引力。本综述强调了脂联素作为抗炎和心脏保护激素的生理作用,以及它在成人、儿童和青少年心血管系统中作为生物标志物和潜在治疗工具的作用。脂联素系统可被视为一种有助于在细胞和分子水平上重塑心血管系统的救援激素。应考虑脂联素与心血管死亡率相关的矛盾作用。